Read the latest news from regional and global sources, presenting different voices and perspectives.

India eyes Tanzania’s growing pharmaceutical industry
Mumbai. Tanzania’s pharmaceutical industry is attracting growing interest from Indian investors keen to establish local manufacturing plants, as the country makes steady progress in developing the sector. According to the Pharmaceuticals Export...

STAT+: Braced for details on Trump’s ‘most favored nation’ policy, pharma industry is still waiting
WASHINGTON — Executives at pharmaceutical companies have been bracing for more information from the Trump administration this week about how it planned to lower drug prices. That information has not yet arrived, despite the administration’s...

UK Pharmaceutical industry at risk from government's 'sky-high and unpredictable' rebates system
By CALUM MUIRHEAD Updated: 17:00 EDT, 11 June 2025 The UK’s status as a leader in medical research is at risk from ‘sky-high and unpredictable’ repayments pharmaceutical firms hand the Government, says an industry boss. Richard Torbett, chief...

CMS Seeks Healthcare Industry Input on Future of Digital Health
Healthcare stakeholders have a critical opportunity to shape the future of digital health technology in Medicare. Providers, payers, technology companies, life sciences organizations, and all other stakeholders are invited to provide public...

STAT+: As drug price target deadline looms, pharma companies weigh options
WASHINGTON — Trump administration officials are expected to release more details on their plan to lower prescription drug prices in the coming days and have been meeting with pharmaceutical industry leaders about the potential impacts. The drug...

Polycystic Kidney Disease Pipeline Appears Robust With 8+ Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight
(MENAFN- GetNews) DelveInsight's, “Polycystic Kidney Diseases Pipeline Insight, 2025” report provides comprehensive insights about 8+ companie s and 10+ pipeline drugs in Polycystic Kidney Diseases pipeline landscape. It covers the Polycystic...

Alzheimer's Disease Pipeline Appears Robust With 200+ Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight
(MENAFN- GetNews) DelveInsight's,“ Alzheimer's Disease Pipeline Insight 2025 ” report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in Alzheimer's disease pipeline landscape. It covers the pipeline drug profiles,...

Systemic Sclerosis Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight
(MENAFN- GetNews) DelveInsight's, “Systemic Sclerosis Pipeline Insight 2025” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Systemic Sclerosis pipeline landscape. It covers the Systemic Sclerosis pipeline drug...

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry
On June 9, 2025, Secretary of Health and Human Services Robert F. Kennedy Jr. announced the dismissal of all 17 members of the Advisory Committee on Immunization Practices (ACIP), a Centers of Disease Control and Prevention (CDC)-affiliated body...

Startup founder wants to use AI for the mental health industry
Cole Smith, a St. Petersburg-based entrepreneur, has created an AI platform that enhances the therapy experience for both therapists and patients. Opal, which launched earlier this year, was a passion project from the beginning. As a student at...

US pharma industry's lead under threat
US preeminence in the pharmaceutical industry is under threat, two experts argued. Drug discovery was once led by private companies, but now half of new patents stem from academia, with US institutions accounting for 87% of those, Kevin Gardner...
Overcoming The Pharmaceutical Supply Chain Disruptions
The pharmaceutical industry is undergoing a profound shift as it faces enormous challenges in its supply chain operations. The recent global events, which include the COVID-19 pandemic, have highlighted the susceptibility that is inherent in...

Can ‘reputational pull’ save biotech from pharma’s image problem?
Pharma’s reputation isn’t doing so great. Hot-button issues like drug pricing have chipped away at the industry’s image in the eyes of the public and potential investors. An opioid epidemic and medical misinformation have eroded trust. And in...

The Front Lines of Tuberculosis Vaccine Research
“For me personally, this project is very close to my heart. I spent about a decade at Novartis and GSK, and I’ve brought that experience to Gates MRI to focus on diseases that disproportionately affect underserved populations and present...

Concerns rise over ACIP's new membership
Health and Human Services (HHS) Secretary Robert F Kennedy Jr has named eight new members of the CDC's vaccine advisory committee after firing all 17 experts earlier this week, and his picks include people known to hold contrarian views on...

Understanding the Challenges Preventing Cancer Patients from Joining Trials
In a recent video interview with Applied Clinical Trials, Matt Robinson, PhD, senior director, oncology research program, National Comprehensive Cancer Network (NCCN), discussed the current state and challenges of cancer patient participation in...
Anting medical industry park’s third phase to begin operation
The third phase of Shanghai Anting International Medical Industry Park is expected to go into operation this year. The park along Bao’an Highway in Jiading District recently completed and obtained the property certificate. Upon activation, the...

Direct-to-Consumer Pharmacies: Why Skipping the Counter Puts Patients at Risk
The uptick in pharmaceutical companies selling their medications directly to consumers, such as Pfizer Inc,1 Eli Lilly and Company2 and Novo Nordisk Inc,3 may be compromising the patient’s overall health. This may be especially true in the...

Your UTI risk could increase this summer - key signs of infection
It is estimated that over half of all women in the UK will have at least one UTI in their lifetime 🚽 A leading pharmacist is warning women that the warmer weather could put them at risk of developing a painful and potentially life-threatening...

Alys Pharmaceuticals Submits ALY-301 Clinical Trial Application in Germany for Cold Urticaria
Alys Pharmaceuticals recently announced it has submitted a clinical trial application to Germany's Paul-Ehrlich-Institut in order to initiate a phase 1/1b trial of ALY-301 for cold urticaria.1 The study will assess the efficacy and safety of the...